Advanced search
Publication Cover
Acta Cardiologica Volume 76, 2021 - Issue 8
Submit an article Journal homepage
151
Views
2
CrossRef citations to date
0
Altmetric
Original Scientific Papers

In-hospital statin initiation characteristics and one-year statin adherence rates in patients hospitalised for acute coronary syndrome

Barış Şimşeka Department of Cardiology, Health Science University, Dr. Siyami Ersek Training and Research Hospital, Istanbul, TurkeyORCID Iconhttps://orcid.org/0000-0001-9412-0035
ORCID Icon,
Tufan Çınarb Department of Cardiology, Health Science University, Sultan Abdülhamid Han Training and Research Hospital, Istanbul, TurkeyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8188-5020
ORCID Icon,
Veysel Ozan Tanıkc Department of Cardiology, Ankara Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara, Turkey
,
Duygu İnana Department of Cardiology, Health Science University, Dr. Siyami Ersek Training and Research Hospital, Istanbul, Turkey
,
İlhan İlker Avcıa Department of Cardiology, Health Science University, Dr. Siyami Ersek Training and Research Hospital, Istanbul, Turkey
,
Gönül Zerena Department of Cardiology, Health Science University, Dr. Siyami Ersek Training and Research Hospital, Istanbul, Turkey
,
Ahmet Ilker Tekkeşina Department of Cardiology, Health Science University, Dr. Siyami Ersek Training and Research Hospital, Istanbul, Turkey
,
Can Yucel Karabaya Department of Cardiology, Health Science University, Dr. Siyami Ersek Training and Research Hospital, Istanbul, TurkeyORCID Iconhttps://orcid.org/0000-0002-9653-9048
ORCID Icon,
Baris Gungora Department of Cardiology, Health Science University, Dr. Siyami Ersek Training and Research Hospital, Istanbul, Turkey
&
Lale Tokgozoglud Department of Cardiology, Hacettepe University Medical Faculty, Ankara, TurkeyORCID Iconhttps://orcid.org/0000-0001-6441-3339
ORCID Icon show all
Pages 852-858 | Received 11 Jun 2020, Accepted 03 Jul 2020, Published online: 17 Jul 2020

References

  • Ibanez B, James S, Agewall S, ESC Scientific Document Group, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119–177.
  • Stenestrand U, Wallentin L, Swedish Register of Cardiac Intensive Care (RIKS-HIA) Early statin treatment following acute myocardial infarction and 1-year survival. JAMA. 2001;285(4):430–436.
  • Schwartz GG, Olsson AG, Ezekowitz MD, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA. 2001;285(13):1711–1718.
  • Mach F, Baigent C, Catapano AL, ESC Scientific Document Group, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111–188.
  • Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140:e596–e646.
  • Vonbank A, Saely CH, Rein P, et al. Current cholesterol guidelines and clinical reality: a comparison of two cohorts of coronary artery disease patients. Swiss Med Wkly. 2013;143:w13828.
  • Tokgözoğlu L, Özdemir R, Altındağ R, et al. Patient characteristics and statin discontinuation-related factors during treatment of hypercholesterolemia: an observational non-interventional study in patients with statin discontinuation (STAY study). Turk Kardiyol Dern Ars. 2016;44(1):53–64.
  • Roffi M, Patrono C, Collet JP, ESC Scientific Document Group, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(3):267–315.
  • Baigent C, Blackwell L, Emberson J, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet. 2010; 376:1670–1681.
  • Tokgözoğlu L, Kaya EB, Erol C, et al. EUROASPIRE III Turkey Study Group. EUROASPIRE III: a comparison between Turkey and Europe [Article in Turkish]. Turk Kardiyol Dern Ars. 2010;38:164–172.
  • Spertus JA, Peterson E, Rumsfeld JS, Cardiovascular Outcomes Research Consortium, et al. The Prospective Registry Evaluating Myocardial Infarction: Events and Recovery (PREMIER)-evaluating the impact of myocardial infarction on patient outcomes. Am Heart J. 2006;151(3):589–597.
  • Arnold SV, Chan PS, Jones PG, Cardiovascular Outcomes Research Consortium, et al. Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health Status (TRIUMPH): design and rationale of a prospective multicenter registry. Circ Cardiovasc Qual Outcomes. 2011;4(4):467–476.
  • De Backer G, Jankowski P, Kotseva K, Study centres, organisations, investigators and other research personnel (National Co-ordinators in each country are indicated by asterisk, et al. Management of dyslipidaemia in patients with coronary heart disease: results from the ESC-EORP EUROASPIRE V survey in 27 countries. Atherosclerosis. 2019;285:135–146.
  • Cannon CP, Blazing MA, Giugliano RP, et al. for the IMPROVE-IT Investigators. Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med. 2015;372(25):2387–2397.
  • Meade T, Sleight P, Collins R, et al. for the Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group. Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial. Lancet. 2010;376:1658–1669.
  • Mert GÖ, Başaran Ö, Mert KU, et al. The reasons of poor lipid target attainment for secondary prevention in real life practice: results from EPHESUS. Int J Clin Pract. 2019;73(9):1–9.
  • Muntner P, Yun H, Sharma P, et al. Ability of low antihypertensive medication adherence to predict statin discontinuation and low statin adherence in patients initiating treatment after a coronary event. Am J Cardiol. 2014;114(6):826–831.
  • Foody JM, Joyce AT, Rudolph AE, et al. Persistence of atorvastatin and simvastatin among patients with and without prior cardiovascular diseases: a US managed care study. Curr Med Res Opin. 2008;24(7):1987–2000.
  • Monaldi B, Bologna G, Costa GG, et al. Adherence to statin treatment following a myocardial infarction: an Italian population-based survey. Clinicoecon Outcomes Res. 2015;7:273–280.
  • Wong MC, Jiang JY, Yan BP, et al. Subjects at risk of discontinuation of lipid-lowering agents: a 6-month cohort study among 12,875 patients in a Chinese population. Clin Ther. 2011;33(5):617–628.
  • Özdemir T, Şahin İ, Avcı İİ, et al. Assessment of factors related to statin non-adherence in patients with established coronary artery disease: a single-center observational study. Turk Kardiyol Dern Ars. 2017;45:723–730.
  • Yildiz Sevgi D, Gunduz A, Altuntas Aydin O, et al. Adherence to antiretroviral therapy in Turkey: results from the ACTHIV-IST Study Group. AIDS Res Hum Retroviruses. 2017;33(12):1192–1198.
  • Doğan V, Başaran Ö, Özlek B, et al. Evaluation of perceptions, knowledge and compliance with guidelines in real-life practice: a survey on the under-treatment of hypercholesterolemia. Turk Kardiyol Dern Ars. 2019;47:599–608.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

A worldwide pioneer in biotechnology.
Bristol Myers Squibb – symposium on hypertrophic cardiomyopathy.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.